MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer

Sung‐Hsin Kuo(National Taiwan University Hospital), Chiun‐Sheng Huang(National Taiwan University Hospital)

Cellular Oncology

May 11, 2023

10.1007/s13402-023-00805-w

Cited by 17

Related Papers

Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

|Cancers|2019|42

Atorvastatin Attenuates Radiotherapy‐Induced Intestinal Damage through Activation of Autophagy and Antioxidant Effects

|Oxidative Medicine and Cellular Longevity|2022|15

CDK4/6 inhibitors synergize with radiotherapy to prime the tumor microenvironment and enhance the antitumor effect of anti-PD-L1 immunotherapy in triple-negative breast cancer

|Journal of Biomedical Science|2025|3

Contribution of Nuclear BCL10 Expression to Tumor Progression and Poor Prognosis of Advanced and/or Metastatic Pancreatic Ductal Adenocarcinoma by Activating NF-κB-Related Signaling

|Research Square|2021|0